Alinia (Romark Laboratories, L.C.)


Welcome to the PulseAid listing for the Alinia drug offered from Romark Laboratories, L.C.. This Antiprotozoal [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Romark Laboratories, L.C.
NON-PROPRIETARY NAME: nitazoxanide
SUBSTANCE NAME: NITAZOXANIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antiprotozoal [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2004-07-21
END MARKETING DATE: 0000-00-00


Alinia HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAlinia from Romark Laboratories, L.C.
LABELER NAME: Romark Laboratories, L.C.
DEA SCHEDULE:
ACTIVE STRENGTH: 500(mg/1)
START MARKETING DATE: 2004-07-21
END MARKETING DATE: 0000-00-00
PRODUCT ID: 67546-111_5c87947c-42a3-f79e-e053-2a91aa0a8e01
PRODUCT NDC: 67546-111
APPLICATION NUMBER: NDA021497

Other NITAZOXANIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalAlinia
Lupin PharmaAlinia
Romark Laboratories, L.C.Alinia